O=[N+]([O-])c1ccc(C2(O)C[N+](c3ccccc3)=C3SCCN32)cc1.[Br-]
The rule of three is typically followed by orally active drugs, which have a molecular weight of <300, a c LogP of ≤3, a hydrogen bond donor count of ≤3 and a hydrogen bond acceptor count of ≤3. Does the molecule comply with the rule of three?